Major health fund cuts discounts for Ozempic amid rising demand

Western Australia’s largest private health insurer will cut rebates on weight loss drugs including Ozempic, saying rising claims have become unsustainable.

HBF, which dominates the health insurance market in Western Australia with 53 per cent of all policies in the state, said growth in claims for weight loss drugs had prompted it to take the decision to reduce profits.

For members who currently have drug coverage, benefits will be completely reduced for some drugs, including Wegovy and some compounded drugs.

The benefits of other medicines will be cut in half, including those containing semaglutide, the active ingredient in Ozempic.

The changes come into effect from August for HBF members undergoing existing treatments.

Popularity leads to scarcity

Ozempic, which was originally developed to help people with diabetes, has surged in popularity as a weight-loss drug since it hit the market in 2021, causing a worldwide shortage.

People taking Ozempic for weight loss are prescribed ‘off-hours’, meaning it is not used for the purposes listed on the Pharmaceutical Benefits Scheme (PBS) and cannot be accessed through the PBS rate $41 per month or $6.60 for concession card holders.

published, Updated

#Major #health #fund #cuts #discounts #Ozempic #rising #demand
Image Source : www.abc.net.au

Leave a Comment